Top Story

Aprepitant effective for CINV prevention in children

March 30, 2015

The addition of aprepitant to ondansetron effectively reduced or prevented chemotherapy-induced nausea and vomiting in pediatric patients who underwent moderately or highly emetogenic chemotherapy, according to results of a randomized, double blind phase 3 trial.

Oral aprepitant, a neurokinin-1 receptor agonist, often is combined with other antiemetic agents to help prevent chemotherapy-induced nausea and vomiting in adults. However, the safety and efficacy of this regimen in children has not been established, according to study background.

Institution Notes

Gynecologic oncologist becomes network's physician director

March 29, 2015
Thomas J. Rutherford, MD, PhD, has been named network physician director of cancer services at Western Connecticut Health Network.Rutherford, a gynecologic oncologist…
Keith Flaherty Institution Notes

Cancer center names director of clinical research

March 28, 2015
Keith Flaherty, MD, has been appointed director of clinical research at Massachusetts General Hospital Cancer Center.
thumbnail for video 4139087567001 Meeting News CoverageVideo

VIDEO: 'Full spectrum' of melanoma prevention, treatment options available

March 27, 2015
SAN FRANCISCO — In this video, Sancy A Leachman, MD, PhD, discusses the latest developments in the prevention and treatment of melanoma the American Academy of…
Marcy Winget, MD In the Journals

Breast conservation surgery plus radiotherapy confers better survival outcomes than mastectomy

March 27, 2015
Women with stage I to stage III breast cancer who underwent breast-conserving surgery plus radiotherapy demonstrated significantly improved all-cause and breast…
More News Headlines »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
thumbnail for video 4126759064001

Solid organ transplant recipients at higher risk for skin cancer

March 22, 2015
SAN FRANCISCO – In this video, Sarah Tuttleton Arron, MD, PhD, FAAD, discusses her research on mortality from…
More »
CME
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
morganatic-roan
morganatic-roan